News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InNexus Biotechnology Inc. (IXS) Appoints Chief Financial Officer



10/20/2011 10:17:17 AM

CHANDLER, Ariz.--(BUSINESS WIRE)--InNexus Biotechnology Inc. (TSX: IXS.V), a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, today announced that it has appointed Angela Giannoccaro as its Chief Financial Officer. Ms. Giannoccaro assumed her role on October 17th, 2011. She will oversee InNexus non-research and development administrative functions in addition to her financial management responsibilities.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES